Company Monitoring Page for Actelion

latest headlines for company on cafepharma

Actelion sees Uptravi price of $160,000-170,000/patient
Yahoo/Reuters
Tue, 01/5/16 - 02:47 pm
Tags:
Actelion, Uptravi, PAH, pulmonary arterial hypertension
Actelion says selexipag to enter U.S. market in January
Yahoo/Reuters
Tue, 12/22/15 - 10:56 am
Tags:
Actelion, selexipag, Uptravi, PAH, pulmonary arterial hypertension
Actelion: We're interested in ZS Pharma, but not dependent on M&A
BioPharma Dive
Thu, 10/22/15 - 09:48 am
Tags:
Actelion, ZS Pharma, M&A
With Opsumit launch rolling, Actelion doesn't 'need' M&A: CEO
Fierce Pharma
Tue, 10/20/15 - 09:53 pm
Tags:
Actelion, Opsumit, M&A, PAH, pulmonary arterial hypertension
Actelion CFO says biotech could make acquisitions exceeding $2.5 bln
Yahoo/Reuters
Tue, 10/20/15 - 09:46 am
Tags:
Actelion, M&A
Actelion raises 2015 earnings forecast after strong drug sales
Yahoo/Reuters
Tue, 10/20/15 - 09:45 am
Tags:
Actelion, earnings
Actelion and ZS Pharma confirm acquisition talks
Marketwatch
Fri, 09/11/15 - 09:52 am
Tags:
Actelion, ZS Pharma
Actelion's Opsumit growth heralds smooth switch off aging Tracleer
Fierce Pharma
Tue, 07/21/15 - 10:34 am
Tags:
Actelion, Opsumit, Tracleer, PAH, pulmonary arterial hypertension
Actelion creates €30M vax startup, Immunocore expands Lilly deal, Cell Therapy seeks PhIII ally
Fierce Biotech
Thu, 07/2/15 - 11:12 am
Tags:
Immunocore, Actelion, vaccines, Eli Lilly, Cell Therapy Group
The latest Shire buyout rumor: An $18.9B bid for Actelion
Fierce Biotech
Mon, 06/8/15 - 11:17 am
Tags:
Shire, M&A, Actelion
Surging Actelion is on the hunt for buyouts amid 'M&A frenzy'
Fierce Biotech
Tue, 04/21/15 - 09:34 am
Tags:
Actelion, M&A
Actelion launches Phase III MS test for ponesimod
Fierce Biotech
Thu, 04/16/15 - 12:31 pm
Tags:
Actelion, MS, multiple sclerosis, ponesimod
Deep dive into Actelion's Uptravi data calms investors as FDA decision date nears
Fierce Biotech
Wed, 03/18/15 - 11:08 am
Tags:
Actelion, Uptravi, PAH, pulmonary arterial hypertension
The top 10 patent losses of 2015
Fierce Pharma
Fri, 12/19/14 - 08:35 am
Tags:
patents, Lantus, Abilify, Copaxone, Neulasta, Tracleer, Namenda, Avodart, Jalyn, Zyvox, Androgel, Synagis, Sanofi, Bristol-Myers Squibb, Otsuka, Teva Pharmaceutical, Amgen, Actelion, Actavis, GSK, Pfizer, AbbVie, AstraZeneca
Actelion Reports Strong Q3 Results, Says It Has Not Received Any Acquisition Offers From US Pharma Giants
Bidness Etc.
Tue, 10/21/14 - 09:22 am
Tags:
Actelion, earnings
Actelion Says U.S. Tax-Inversion Limits Good for Industry
Bloomberg
Tue, 10/21/14 - 08:05 am
Tags:
Actelion, tax inversions, M&A
Actelion Raises Full-Year Profit Forecast on Opsumit
Bloomberg
Tue, 07/22/14 - 08:58 am
Tags:
Actelion, Opsumit, Tracleer, earnings
Perrigo, Actelion Tax Targets Abroad for U.S. Drugmakers
Bloomberg
Mon, 07/21/14 - 09:14 am
Tags:
Perrigo Company, Actelion, Smith & Nephew, M&A, tax inversions
InterMune's A Strong Buy As Esbriet Finally Has The Data Physicians, Patients, And FDA Have Longed For
Seeking Alpha
Sun, 06/15/14 - 06:31 pm
Tags:
InterMune, Esbriet, Actelion, Gilead Sciences
Actelion May Raise Forecast After First-Quarter Earnings
Bloomberg
Thu, 04/17/14 - 08:03 am
Tags:
Actelion, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.